0000842023-12-000005.txt : 20120208
0000842023-12-000005.hdr.sgml : 20120208
20120208132833
ACCESSION NUMBER: 0000842023-12-000005
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120208
FILED AS OF DATE: 20120208
DATE AS OF CHANGE: 20120208
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChemoCentryx, Inc.
CENTRAL INDEX KEY: 0001340652
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943254365
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 650-210-2900
MAIL ADDRESS:
STREET 1: 850 MAUDE AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TECHNE CORP /MN/
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35420
FILM NUMBER: 12580903
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0204
3
2012-02-08
0
0001340652
ChemoCentryx, Inc.
CCXI
0000842023
TECHNE CORP /MN/
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
0
1
0
Series A Preferred Stock
Common Stock
2500000
D
Series B Preferred Stock
Common Stock
973418
D
Series C Preferred Stock
Common Stock
611574
D
Series D Preferred Stock
Common Stock
628574
D
Convertible Promissory Note
Common Stock
1021490
D
The Issuer's Preferred Stock has no expiration date, is convertible at any time, in whole or in part, at the election of the holder, and will automatically convert upon the closing of the Issuer's initial public offering (the "IPO") at a conversion ratio of one share of Common Stock for every two shares of Preferred Stock, rounded down to the next whole number, for no additional consideration.
The principal amount of the Convertible Promissory Note, plus accrued interest thereon, will automatically convert into shares of Common Stock upon the closing of the IPO at a conversion price of $10.00 per share, the per share amount of the Common Stock being sold in the IPO.
Assumes the IPO closing will occur on or about February 13, 2012.
Thomas E. Oland, CEO
2012-02-08